Smoking and risk of schizophrenia: new study finds a dose-response relationship

shutterstock_785405

Marcus Munafò looks at the mounting evidence about smoking and risk of schizophrenia, including a new case-control study that provides clear evidence of a prospective association between cigarette smoking and a subsequent diagnosis of schizophrenia.

[read the full story...]

Quetiapine for schizophrenia: more transparency needed in clinical trial reporting

shutterstock_122223547

Andrew Shepherd reports on a recent systematic review, meta-analysis and reappraisal of Quetiapine for schizophrenia, which concludes that Quetiapine IR has a small beneficial effect on psychotic symptoms, but also leads to weight gain and sedation.

[read the full story...]

CBTp and medication in the treatment of psychosis: summarising the best evidence

shutterstock_158430557

Clive Adams presents a summary of the latest evidence for CBTp and medication in the treatment of psychosis. This blog was published alongside Clive’s talk at the Understanding Psychosis and Schizophrenia conference in Bath on 11 June 2015

[read the full story...]

Placebo effect in psychiatry: what do we really know?

shutterstock_125031905

David Steele summarises a review of systematic reviews and meta-analyses, which looks at the mediators and moderators of the placebo effect in psychiatry.

[read the full story...]

Promoting smoking cessation in people with schizophrenia

shutterstock_276469196

Meg Fluharty summarises a recent clinical overview of smoking cessation in people with severe mental illness, which provides useful practical advice to clinicians who are trying to help service users with schizophrenia, psychosis and other conditions to quit smoking

[read the full story...]

The more psychotic you are, the more benefit there is in taking antipsychotics

shutterstock_122223547

John Baker reviews a recent participant-level meta-analysis of six placebo-controlled studies, which looks at the initial severity of schizophrenia and the efficacy of antipsychotics including Olanzapine, Risperidone and Amisulpride.

[read the full story...]

Do we stigmatise mental illness more as we age?

shutterstock_186330554

Raluca Lucacel writes her debut blog about an age-period-cohort analysis, which investigates how attitudes towards people with mental illness worsen during the course of life.

[read the full story...]

Psychosis and schizophrenia in adults: new quality standard from NICE

shutterstock_158811926

Consultant Psychiatrist Samei Huda provides a personal critique of the new NICE quality standard on psychosis and schizophrenia in adults. Read his thoughts and join the discussion!

[read the full story...]

People with severe mental illness are more likely to be victims of violent and non-violent crime

shutterstock_74403016

Vishal Bhavsar summarises a recent cross-sectional study of violent and non-violent crime against adults with severe mental illness, which finds that service users were five times more likely to be victims of assault, and three times more likely to be victims of household acquisitive crime.

[read the full story...]